Scott C Bresler
Overview
Explore the profile of Scott C Bresler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
602
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Durgin J, Zoumberos N, Novice T, Fullen D, Hristov A, Lowe L, et al.
Histopathology
. 2025 Feb;
PMID: 39976080
Aims: BAP1-inactivated melanocytic tumours (BIMTs) occur sporadically and in association with a familial tumour predisposition syndrome involving germline mutations in the BRCA1-associated protein-1 (BAP1) gene. Here we report the clinical...
2.
Plotzke J, Manthei D, Fullen D, Chan M, Bresler S, Xiao H, et al.
Arch Pathol Lab Med
. 2024 Dec;
PMID: 39722598
Context.—: Patients with melanoma can develop second tumors representing either metastases or new primary melanoma. This distinction has profound implications for management. Although clinicopathologic features are often sufficient, molecular assays...
3.
Wang M, Bresler S, Chan M, Patel R, Chapel D
Int J Gynecol Pathol
. 2024 Aug;
44(2):112-119.
PMID: 39173136
The vulva and perineum are rarely involved by acantholytic dyskeratoses, including Hailey-Hailey disease, Darier disease, papular acantholytic dyskeratosis of the genitocrural area, acantholytic dyskeratotic acanthoma, and warty dyskeratoma. These entities...
4.
Saleh J, Whittington C, Bresler S, Patel R
Surg Pathol Clin
. 2024 Jan;
17(1):153-158.
PMID: 38278604
Pleomorphic dermal sarcoma (PDS) is a rare cutaneous/subcutaneous neoplasm of purported mesenchymal differentiation that exists along a clinicopathologic spectrum with atypical fibroxanthoma (AFX). While PDS and AFX share histopathologic and...
5.
Cole D, Menge T, Lowe L, Chan M, Bresler S
Am J Dermatopathol
. 2023 Dec;
46(6):337-345.
PMID: 38133527
Introduction: Although many individual cases and small series of toxic erythema of chemotherapy (TEC) have been described, the full spectrum of findings is not well understood. Objective: To provide a...
6.
Bresler S, Gosnell H, Ko J, Angeles C, Ronen S, Billings S, et al.
Am J Surg Pathol
. 2023 Sep;
47(12):1417-1424.
PMID: 37727934
Subcutaneous leiomyosarcoma (LMS) is a rare, poorly understood variant. The current literature on the subject is sparse, consisting of isolated case reports and small clinicopathologic studies compromised by the inclusion...
7.
LaMonica L, Lang-Houser M, Bresler S, Mervak J
JAAD Case Rep
. 2023 Jul;
38:82-85.
PMID: 37456515
No abstract available.
8.
Menge T, Durgin J, Hrycaj S, Brent A, Patel R, Harms P, et al.
Mod Pathol
. 2023 Jun;
36(10):100265.
PMID: 37391171
Basal cell carcinoma (BCC) is the most common human malignancy and is a leading cause of nonmelanoma skin cancer-related morbidity. BCC has several histologic mimics which may have treatment and...
9.
Whittington C, Saleh J, Bresler S, Patel R
Arch Pathol Lab Med
. 2023 Jun;
148(6):659-665.
PMID: 37327190
Context.—: Hypertrophic lichen planus (HLP) is a variant of lichen planus that can be difficult to diagnose based on histopathologic features alone. Thus, patient clinical history and clinicopathologic correlation are...
10.
Saleh J, Whittington C, Bresler S, Patel R
Hum Pathol
. 2023 Apr;
140:53-65.
PMID: 37059271
Cutaneous vascular tumors constitute a heterogeneous group of entities that share overlapping morphologic and immunohistochemical features, which can be diagnostically challenging for pathologists and dermatopathologists. Our understanding and knowledge of...